{"transactions":[{"id":1087247,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Common Warrants (right to buy)","published_at":"2025-07-15T20:15:28.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":16793,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,793 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 16,793 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":16793,"derivative":{"exercise_price":1.875,"expiration_date":"2030-07-11","underlying":"Common Shares","underlying_shares":16793},"source":{"system":"sec-edgar","filing":"0001415889-25-019776","document":"form4-07152025_040723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019776/form4-07152025_040723.xml","form_type":"4"}},{"id":1087246,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Common Warrants (right to buy)","published_at":"2025-07-15T20:15:28.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":16793,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,793 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 16,793 shares of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully vested and exercisable."}],"balance_after":16793,"derivative":{"exercise_price":1.5,"expiration_date":"2026-07-11","underlying":"Common Shares","underlying_shares":16793},"source":{"system":"sec-edgar","filing":"0001415889-25-019776","document":"form4-07152025_040723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019776/form4-07152025_040723.xml","form_type":"4"}},{"id":1087245,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-15T20:15:28.000Z","date":"2025-07-11","kind":"grant","planned":false,"acquired":true,"shares":16666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 16,793 Issuer Units purchased by the Reporting Person for $1.50 per Unit. Each Unit consists of one common share, one Series A common warrant and one Series B common warrant, each warrant represents the right to purchase 16,793 shares of common stock."}],"balance_after":16793,"source":{"system":"sec-edgar","filing":"0001415889-25-019776","document":"form4-07152025_040723.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000141588925019776/form4-07152025_040723.xml","form_type":"4"}},{"id":1860146,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-09T20:21:35.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 7, 2023, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":3.86,"expiration_date":"2033-06-07","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-035838","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919123035838/doc4.xml","form_type":"4"}},{"id":2133397,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-21T23:02:01.000Z","date":"2022-10-21","kind":"purchase","acquired":true,"shares":4000,"price":5.26,"value":21040.0,"ownership":{"direct":false,"nature":"By: Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of several including the Reporting Person's spouse. The Reporting Person's spouse is a co-executor of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-22-054326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919122054326/doc4.xml","form_type":"4"}},{"id":2133396,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-10-21T23:02:01.000Z","date":"2022-10-20","kind":"purchase","acquired":true,"shares":10000,"price":5.29,"value":52900.0,"ownership":{"direct":false,"nature":"By: The Rodriguez and Liebert Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.24 to $5.30 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-22-054326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919122054326/doc4.xml","form_type":"4"}},{"id":2158208,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-09-15T20:30:26.000Z","date":"2022-09-14","kind":"other","acquired":true,"shares":127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata distribution without additional consideration to the Reporting Person from a limited liability company in which the Reporting\nPerson is a member."}],"balance_after":127,"source":{"system":"sec-edgar","filing":"0001209191-22-050075","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919122050075/doc4.xml","form_type":"4"}},{"id":2187860,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-08-11T22:00:10.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on August 5, 2022, provided that the option will in any case be fully vested\non the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each\nsuch vesting date."}],"balance_after":30000,"derivative":{"exercise_price":6.07,"expiration_date":"2032-07-05","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-045468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919122045468/doc4.xml","form_type":"4"}},{"id":2621960,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-29T21:37:39.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in twelve (12) equal monthly installments, beginning on July 14, 2021, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":5.54,"expiration_date":"2031-06-14","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-21-048567","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919121048567/doc4.xml","form_type":"4"}},{"id":3118196,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-08T23:04:16.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in equal monthly installments over the 12 months commencing July 5, 2020, provided that the shares subject to this option shall vest in full on the date of Issuer's 2021 annual meeting of shareholders, subject to recipient continuing to provide service to the Issuer through such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":3.74,"expiration_date":"2030-06-05","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-035114","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919120035114/doc4.xml","form_type":"4"}},{"id":3371003,"issuer":{"id":6561,"kind":"organization","name":"Milestone Pharmaceuticals Inc."},"owners":[{"id":77499,"kind":"person","name":"Liebert Debra K.","position":1,"cik":"0001772891","reported_name":"Liebert Debra K.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-11-14T23:40:07.000Z","date":"2019-11-12","kind":"grant","acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest in equal monthly installments, beginning on December 12, 2019, over a period of three years, subject to the Reporting Person continuing to provide service through each such vesting date."}],"balance_after":19000,"derivative":{"exercise_price":17.78,"expiration_date":"2029-11-12","underlying":"Common Shares","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001209191-19-056625","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408443/000120919119056625/doc4.xml","form_type":"4"}}]}